4//SEC Filing
Englese Thomas 4
Accession 0001415889-23-004626
CIK 0001708527other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 9:18 PM ET
Size
9.0 KB
Accession
0001415889-23-004626
Insider Transaction Report
Form 4
Englese Thomas
Chief Commercial Officer
Transactions
- Sale
Class A Common Stock
2023-03-09$4.30/sh−289$1,243→ 17,917 total - Exercise/Conversion
Restricted Stock Units
2023-03-08−937→ 1,875 total→ Class A Common Stock (937 underlying) - Exercise/Conversion
Class A Common Stock
2023-03-08+937→ 18,206 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs").
- [F2]Represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
- [F3]On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022.
Documents
Issuer
AZIYO BIOLOGICS, INC.
CIK 0001708527
Entity typeother
Related Parties
1- filerCIK 0001825799
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 9:18 PM ET
- Size
- 9.0 KB